Clinical Trial Update: H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating H101 in combination with transarterial chemoembolization (TACE) for primary hepatocellular carcinoma with portal vein thromb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Portal Vein Thrombosis

Drugs mentioned

• H101 (oncolytic adenovirus H101)
• Transarterial chemoembolization (TACE)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Primary Hepatocellular Carcinoma, Portal Vein Thrombosis | Phase 2 | Status: UNKNOWN